Anti-apoptotic function of T-KTS+, T-KTS-, WT1+/+ and WT1+/- isoforms in breast cancer

Asian Biomedicine

Volumn 4, Issue 5, 2010, Pages 711-720

  Graidist, Potchanapond ^a   Nawakhanitworakul, Raphatphon ^a   Saekoo, Jiraporn ^a   Dechsukhum, Chavaboon ^b   Fujise, Ken ^c  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b SURANAREE UNIVERSITY OF TECHNOLOGY   (Thailand)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Anti apoptosis; MCF 7; Truncated WT1; WT1

Indexed keywords

EID: 84871696567     PISSN: 19057415     EISSN: 1875855X     Source Type: Journal    
DOI: 10.2478/abm-2010-0093     Document Type: Article

References (25)

1. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns, GA. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 1990; 34:774-8.
2. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, et al. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood. 1994; 84: 3071-9. (Pubitemid 24328100)
3. Inoue K, Tamaki H, Ogawa H, Oka Y, Soma T, Tatekawa T, et al. Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood. 1998; 91:2969-76. (Pubitemid 28227548)
4. Chen Z. The possible role and application of WT1 in human leukemia. Int J Hematol. 2001; 73:39-46. (Pubitemid 33758837)
5. Algar E, Khromykh T, Smith S, Blackburn D, Bryson G, Smith P. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene. 1996; 12:1005-14. (Pubitemid 26104442)
6. Yamagami T, Sugiyama H, Inoue K, Ogawa H, Tatekawa T, Hirata M, et al. Growth inhibition of human leukemic cells by WT1 (Wilms' tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood. 1996; 87:2878-84. (Pubitemid 26102238)
7. Smith SI, Down M, Boyd AW, Li CL. Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice. Cancer Res. 2000; 60:808-14. (Pubitemid 30129506)
8. Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, et al. Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumor despite tumor specific promoter methylation. Cancer Res. 2001; 61: 921-5. (Pubitemid 32174404)
9. Navakanit R, Graidist P, Leeanansaksiri W, Dechsukum C. Growth inhibition of breast cancer cell line MCF-7 by siRNA silencing of Wilm tumor 1 gene. J Med Assoc Thai. 2007; 90:2416-21. (Pubitemid 350256447)
10. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE. Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc Natl Acad Sci USA. 1991; 88:9618-22. (Pubitemid 21915682)
11. Yang L, Han Y, Saurez Saiz F, Minden MD. A tumor suppressor and oncogene: the WT1 story. Leukemia. 2007; 21:868-76. (Pubitemid 46672061)
12. Wang ZY, Qiu QQ, Deuel TF. The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. J Biol Chem. 1993; 268:9172-5. (Pubitemid 23145954)
13. Dechsukhum C, Ware JL, Ferreira-Gonalez A, Wilkinson DS, Garrett CT. Detection of novel truncated WT1 transcription in human neoplasia. Mol Diag. 2000; 5: 1-12.
14. Loeb DM. WT1 influences apoptosis through transcriptional regulation of Bcl-2 family members. Cell Cycle. 2006; 5:1249-53. (Pubitemid 43894273)
15. Ito K, Oji Y, Tatsumi N, Shimizu S, Kanai Y, Nakazawa T, et al. Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway. Oncogene. 2006; 25:4217-29. (Pubitemid 44079455)
16. Burwell EA, McCarty GP, Simpson LA, Thompson KA, Loeb DM. Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells. Oncogene. 2007; 26:3423-30. (Pubitemid 46788886)
17. Simpson LA, Burwell EA, Thompson KA, Shahnaz S, Chen AR, Loeb DM. The antiapoptotic gene A1/BEFL1 is a WT1 target gene that mediates granulocytic differentiation and resistance to chemotherapy. Blood. 2006; 107:4695-702. (Pubitemid 43882617)
18. Lissy NA, Davis PK, Irwin M, Kaelin WG, Dowdy SF. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature. 2000; 407:642-5.
19. Drummond IA, Rupprecht HD, Rohwer-Nutter P, Lopez- Guisa JM, Madden SL, Rauscher FJ, et al. DNA recognition by splicing variant of the Wilms' tumor suppressor, WT1. Mol Cell Biol. 1994; 14:3800-9. (Pubitemid 24160787)
20. Nichols KE, Re GG, Yan YX, Garvin AJ, Haber DA. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells. Cancer Res. 1995; 55:4540-3.
21. Caricasole A, Duarte A, Larsson SH, Hastie ND, Little M, Holmes G, et al. RNA binding by the Wilms' tumor suppressor zinc finger proteins. Proc Natl Acad Sci USA. 1996; 93:7562-6. (Pubitemid 26277075)
22. Hohenstein P, Hastie DN. The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet. 2006; 2: R196-201. (Pubitemid 44446794)
23. Jomgeow T, Oji Y, Tsuji N, Ikeda Y, Ito K, Tsuda A, et al. Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Sci. 2006; 97: 259-70.
24. Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, et al. Expression of the Wilm's tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res. 1999; 90:194-204. (Pubitemid 29112320)
25. Tatsumi N, Oji Y, Tsuji N, Tsuda A, Higashio M, Aoyagi S, et al. Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors. Int J Oncol. 2008; 32:701-11. (Pubitemid 351330477)